Abstract:Liver fibrosis is a reparative response to injury that arises from various etiologies, characterized by activation of hepatic stellate cells (HSCs). Periostin, a secreted matricellular protein, has been reported to participate in tissue development and regeneration. However, its involvement in liver fibrosis remains unknown. This study investigated the roles and mechanisms of Periostin in phenotypic transition of HSCs and relevant abnormal cellular crosstalk during liver fibrosis. The fate of hepatic stellate cells (HSCs) during liver fibrogenesis was investigated using single-cell and bulk RNA sequencing profiles, which revealed a significant proliferation of activated HSCs (aHSCs) in fibrotic livers of both humans and mice. αSMA -TK mice were used to demonstrate that depletion of proliferative aHSCs attenuates liver fibrosis induced by carbon tetrachloride and 3,5-diethoxycarbonyl-1,4-dihydrocollidine. Through integrating data from single-cell and bulk sequencing, Periostin was identified as a distinctive hallmark of proliferative aHSC subpopulation. Elevated levels of Periostin were detected in fibrotic livers of both humans and mice, primarily within aHSCs. However, hepatic Periostin levels were decreased along with depletion of proliferative aHSCs. Deficiency of Periostin led to reduced liver fibrosis and suppressed hepatocyte epithelial-mesenchymal transition (EMT). Periostin-overexpressing HSCs, exhibiting a proliferative aHSC phenotype, release bone morphogenetic protein-1 (Bmp-1), which activates EGFR signaling, inducing hepatocyte EMT and contributing to liver fibrosis. In conclusion, Periostin in aHSCs drives their acquisition of a proliferative phenotype and the release of Bmp-1. Proliferative aHSC subpopulation-derived Bmp-1 induces hepatocyte EMT via EGFR signaling, promoting liver fibrogenesis. Bmp-1 and Periostin should be potential therapeutic targets for liver fibrosis.

In Vitro Generation of Myofibroblasts-Like Cells from Liver Epithelial Progenitor Cells of Rhesus Monkey ( Macaca Mulatta )

Fibroblasts Derive from Hepatocytes in Liver Fibrosis via Epithelial to Mesenchymal Transition

The ratio of transforming growth factor-β1/bone morphogenetic protein-7 in the progression of the epithelial-mesenchymal transition contributes to rat liver fibrosis.

Culture of Newborn Monkey Liver Epithelial Progenitor Cells in Chemical Defined Serum-Free Medium

Liver Epithelioid Progenitor Cells Derived from Fetal Luxi Bovine Alleviate Liver Fibrosis

Epithelial-mesenchymal transition in hepatic fibrosis

Origin of myofibroblasts in the fibrotic liver in mice

Myofibroblasts in Normal and Fibrotic Liver in Different Animal Species

Conversion of Fibroblasts to Hepatocyte-Like Cells in Vivo.

Single Cell RNA Sequencing Identifies Subsets of Hepatic Stellate Cells and Myofibroblasts in Liver Fibrosis

Single‐Cell Transcriptomic Analysis Reveals a Hepatic Stellate Cell–Activation Roadmap and Myofibroblast Origin During Liver Fibrosis in Mice

Myofibroblast Induces Hepatocyte-to-ductal Metaplasia Via Laminin–ɑvβ6 Integrin in Liver Fibrosis

Myofibroblasts Control the Proliferation of Fetal Hepatoblasts and Their Differentiated Cholangiocytes During the Hepatoblast-to-cholangiocyte Transition

Reversible conversion of epithelial and mesenchymal phenotypes in SV40 large T antigen-immortalized rat liver cell lines

Perivenous Stellate Cells Are the Main Source of Myofibroblasts and Cancer‐Associated Fibroblasts Formed After Chronic Liver Injuries

Converting Skin Fibroblasts into Hepatic-Like Cells by Transient Programming

Direct Reprogramming of Hepatic Myofibroblasts into Hepatocytes In Vivo Attenuates Liver Fibrosis

Regulating the cell shift of endothelial cell-like myofibroblasts in pulmonary fibrosis

Contribution of epithelial-derived fibroblasts to bleomycin-induced lung fibrosis.

A novel activation model for myofibroblasts derived from hepatic stellate cells in fibrotic liver

Activated hepatic stellate cell-derived Bmp-1 induces liver fibrosis via mediating hepatocyte epithelial-mesenchymal transition